# China NMPA Product Recall - Streptomycin Susceptibility Testing Kit for Mycobacteria (Fluorescence Method) BD BACTECT™ MGIT™ 960 STR 4.0 Kit

Source: https://www.globalkeysolutions.net/records/china_product_recall/becton-dickinson-and-company/05f19307-4c08-466c-ac6f-07d1e697b0b1/
Source feed: China

> China NMPA product recall for Streptomycin Susceptibility Testing Kit for Mycobacteria (Fluorescence Method) BD BACTECT™ MGIT™ 960 STR 4.0 Kit by Becton, Dickinson and Company published October 22, 2025. Recall level: Level 2 Recall. The National Medical Products Administration (NMPA) announced on October 22, 2025, a voluntary recal

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Becton, Dickinson and Company Streptomycin Susceptibility Testing Kit for Mycobacteria (Fluorescence Method) BD BACTEC™ MGIT™ 960 STR 4.0 Kit Active Recall
- Company Name: Becton, Dickinson and Company
- Publication Date: 2025-10-22
- Product Name: Streptomycin Susceptibility Testing Kit for Mycobacteria (Fluorescence Method) BD BACTECT™ MGIT™ 960 STR 4.0 Kit
- Recall Level: Level 2 Recall
- Recall Reason: The expiration date on the reagent label of the streptomycin solution vial in a specific batch of mycobacterial susceptibility testing kit was incorrect.
- Discovering Company: Becton, Dickinson and Company
- Manufacturing Company: Becton, Dickinson and Company
- Summary: The National Medical Products Administration (NMPA) announced on October 22, 2025, a voluntary recall initiated by Becton, Dickinson and Company (BD). The recall pertains to the Streptomycin Susceptibility Testing Kit for Mycobacteria (Fluorescent Method) BD BACTECT™ MGIT™ 960 STR 4.0 Kit. The manufacturer, Becton, Dickinson and Company, discovered an incorrect expiration date on the reagent label of the streptomycin solution vial in a specific batch of the testing kit. This labeling discrepancy prompted the company to proactively initiate the recall. The NMPA has classified this as a Level II recall, which signifies a situation where the use of or exposure to the affected product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. The official notice, indexed as JGXX-2025-10152, refers to an attached "Medical Device Recall Event Report Form" for comprehensive details regarding the affected product models, specifications, and batch numbers. This action demonstrates the NMPA's regulatory oversight in maintaining medical device integrity and BD's commitment to addressing critical product quality issues.

Company: https://www.globalkeysolutions.net/companies/becton-dickinson-and-company/584ebc66-20ed-4c0c-8447-169c00c667fd/